XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive ...

There are hurdles to using phages to target bacteria. Much like our bodies have immune mechanisms to fight off viruses, bacteria have also evolved defenses against phage infections. One such defense ...